financetom
Business
financetom
/
Business
/
DBV Technologies Says ADS Ratio Change to be Effective June 7
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DBV Technologies Says ADS Ratio Change to be Effective June 7
May 31, 2024 8:16 AM

10:46 AM EDT, 05/31/2024 (MT Newswires) -- DBV Technologies ( DBVT ) said Friday the change in the ratio of its American depositary shares to ordinary shares to the new ratio of one ADS to one ordinary share is expected to be effective around June 7 instead of Monday.

The current ratio is one ADS to one-half of a share, the company said.

For ADS holders, the ratio change will be equivalent to a 1-for-2 reverse ADS split, and this is intended to enable the company to regain compliance with Nasdaq's minimum bid price requirement, according to a statement.

Price: 0.54, Change: -0.03, Percent Change: -5.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fairchild Gold to Acquire Emergent Metals Golden Arrow Project in Nevada
Fairchild Gold to Acquire Emergent Metals Golden Arrow Project in Nevada
Sep 29, 2025
04:50 PM EDT, 09/29/2025 (MT Newswires) -- Fairchild Gold ( FCHDF ) on Monday said it entered into a Memorandum of Understanding (MOU) to acquire a 100% interest in the Golden Arrow Project in Nevada from Emergent Metals ( EGMCF ) . Under the MOU, Fairchild agreed to pay a non-refundable US$250,000 upon signing and an additional US$350,000 upon receipt...
Metsera's MET-097i Delivers Weight Loss Gains, Moves to Phase 3 Trials
Metsera's MET-097i Delivers Weight Loss Gains, Moves to Phase 3 Trials
Sep 29, 2025
04:47 PM EDT, 09/29/2025 (MT Newswires) -- Metsera ( MTSR ) reported positive Phase 2b results for its ultra-long acting GLP-1 candidate MET-097i, demonstrating strong weight loss efficacy and good tolerability, with the data supporting a Phase 3 start later this year. In one study, MET-097i led to up to 14.1% placebo-adjusted weight loss at 28 weeks, showing no plateau...
AnaptysBio Mulls Splitting Company Into Two Firms by 2026-end; Shares Rise
AnaptysBio Mulls Splitting Company Into Two Firms by 2026-end; Shares Rise
Sep 29, 2025
04:51 PM EDT, 09/29/2025 (MT Newswires) -- AnaptysBio ( ANAB ) said late Monday its board approved plans to explore splitting the company into two separate publicly traded firms, Royalty Management Co and Biopharma Co, by the end of 2026. The royalty management company will oversee royalties and milestone payments from financial partnerships. The biopharma firm will focus on the...
UniQure Closes $345 Million Public Offering
UniQure Closes $345 Million Public Offering
Sep 29, 2025
04:48 PM EDT, 09/29/2025 (MT Newswires) -- UniQure ( QURE ) said Monday it closed an underwritten public offering of about 6.7 million shares at $47.50 per share, for gross proceeds of roughly $345 million. The offering includes 947,368 shares issued under the exercise in full by the underwriters of an option to buy more shares, and in lieu of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved